ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,331,603 | -2.4% | 11,189 | +46.1% | 0.00% | 0.0% |
| Q2 2023 | $1,364,223 | +7.2% | 7,656 | -0.8% | 0.00% | 0.0% |
| Q1 2023 | $1,272,996 | +49.8% | 7,717 | +43.0% | 0.00% | 0.0% |
| Q4 2022 | $850,077 | -3.4% | 5,398 | -7.6% | 0.00% | 0.0% |
| Q3 2022 | $880,000 | +69.9% | 5,841 | +85.4% | 0.00% | +100.0% |
| Q2 2022 | $518,000 | -35.0% | 3,151 | -12.0% | 0.00% | -50.0% |
| Q1 2022 | $797,000 | -15.4% | 3,581 | -9.7% | 0.00% | 0.0% |
| Q4 2021 | $942,000 | +2.8% | 3,967 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $916,000 | +8.1% | 3,925 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $847,000 | -10.2% | 4,115 | -10.3% | 0.00% | 0.0% |
| Q1 2021 | $943,000 | -28.8% | 4,590 | -25.6% | 0.00% | -33.3% |
| Q4 2020 | $1,324,000 | -22.9% | 6,172 | -34.3% | 0.00% | -40.0% |
| Q3 2020 | $1,718,000 | -0.9% | 9,398 | -0.1% | 0.01% | -16.7% |
| Q2 2020 | $1,733,000 | -17.5% | 9,403 | -9.7% | 0.01% | -33.3% |
| Q1 2020 | $2,101,000 | -34.9% | 10,414 | -39.6% | 0.01% | -10.0% |
| Q4 2019 | $3,229,000 | -69.8% | 17,255 | -74.3% | 0.01% | -74.4% |
| Q3 2019 | $10,698,000 | -52.9% | 67,029 | -25.6% | 0.04% | -55.2% |
| Q2 2019 | $22,710,000 | -0.6% | 90,152 | -5.6% | 0.09% | -8.4% |
| Q1 2019 | $22,851,000 | +9.2% | 95,478 | +4.8% | 0.10% | -13.6% |
| Q4 2018 | $20,926,000 | -14.2% | 91,130 | +5.6% | 0.11% | 0.0% |
| Q3 2018 | $24,397,000 | -2.4% | 86,286 | +1.4% | 0.11% | -13.4% |
| Q2 2018 | $24,996,000 | +60.2% | 85,121 | +37.7% | 0.13% | +41.1% |
| Q1 2018 | $15,604,000 | +46.1% | 61,821 | +25.0% | 0.09% | +34.3% |
| Q4 2017 | $10,681,000 | +378.8% | 49,448 | +312.0% | 0.07% | +378.6% |
| Q3 2017 | $2,231,000 | +13.4% | 12,003 | +5.3% | 0.01% | 0.0% |
| Q2 2017 | $1,967,000 | +45.9% | 11,404 | +29.2% | 0.01% | +40.0% |
| Q1 2017 | $1,348,000 | -32.1% | 8,830 | -34.4% | 0.01% | -41.2% |
| Q4 2016 | $1,984,000 | -17.1% | 13,463 | -28.9% | 0.02% | -19.0% |
| Q3 2016 | $2,393,000 | +42.1% | 18,933 | +26.8% | 0.02% | +31.2% |
| Q2 2016 | $1,684,000 | -30.1% | 14,936 | -35.4% | 0.02% | -42.9% |
| Q1 2016 | $2,408,000 | +88.9% | 23,134 | +104.6% | 0.03% | +86.7% |
| Q4 2015 | $1,275,000 | – | 11,305 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |